A Phase II randomised controlled trial of oral prednisolone in early diffuse cutaneous systemic sclerosis (PRedSS).

Deborah J Griffiths-JonesYvonne Sylvestre GarciaW David RyderJohn D PaulingFrances HallPeter LanyonSmita BhatKaren DouglasHarsha GunawardenaMohammed AkilMarina AndersonBridget GriffithsFrancesco Del GaldoHazem YoussefRajan MadhokBarbara ArthursMaya BuchKim FligelstoneMohammed ZubairJustin C MasonChristopher P DentonAriane L Herrick

Published in: Rheumatology (Oxford, England) (2023)

ClinicalTrials.gov, https://clinicaltrials.gov, NCT03708718.

Keyphrases

systemic sclerosis
phase ii
clinical trial
open label
interstitial lung disease
study protocol
placebo controlled
phase iii
low grade
rheumatoid arthritis
high grade
idiopathic pulmonary fibrosis